Bringing the fundamentals into focus…
Back to ANI Pharmaceuticals, Inc.
How ANI Pharmaceuticals, Inc. stacks up
ANIP · against 398 other Healthcare companies of similar size
Growth
89/ 100
Near the top of its peers.
Ranked #41 of 399 · scores higher than 88% of peers
Bars: peers in each 10-point band of the growth score46 peers with a growth score of 80–89, including ANIP · Click a bar to see the companies
Why growth scores 89?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth, 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- faster revenue growth over the last year: stronger than 86% of peers. Revenue growth: 30.9% vs peer median 6.1%
- Earnings per share turned from a loss to a profit. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 89% of peers. 3-year revenue growth: 34.6% vs peer median 5.8%
Metric by metric
Position: dot = ANIP, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ANIP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 402 reported | 30.9% | 6.2% | 87% | 33% | |
| Earnings per share growthHigher is better · 221 reported | Not reported | 9.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 391 reported | 34.6% | 6.9% | 88% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ANIP| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 2.8B USD | 99 | 51 | |
| 41 | 1.18T KRW (≈$847M) | 89 | 63 | |
| 41 | 18.7B CNY (≈$2.6B) | 89 | 51 | |
| 41 | 6.8B CNY (≈$959M) | 89 | 43 | |
| 41 | 2.4B EUR (≈$2.6B) | 89 | 69 | |
| 41 | 1.7B USD | 89 | 77 | |
| 41 | 1.8B USD | 89 | 52 | |
| 41 | 2.2B USD | 89 | 32 | |
| 48 | 2.4B SGD (≈$1.8B) | 88 | 79 | |
| 48 | 1.5B AUD (≈$982M) | 88 | 54 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score